The Riverside Company has invested in Transplant Connect (TC), whose iTransplantSM software platform facilitates the donation, transplantation and research of human biologics (including organs, tissues, corneas and birth tissue).
TC is an add-on investment to Riverside’s platform InVita Healthcare Technologies (InVita), which delivers supply chain software solutions to complex medical environments.
Riverside has invested in more than 360 platform and add-on companies in these sectors and possesses a team of industry experts who understand how to grow healthcare companies around the globe. TC is InVita’s third add-on, following Champion Healthcare Technologies in May 2019 and STACS DNA in May 2021.
